Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

May 31, 2007

Conditions

Esophageal Reflux

Interventions

DRUG

Rabeprazole

Trial Locations (1)

University of Kansas Medical Center, Kansas City

All Listed Sponsors

collaborator

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

collaborator

Eisai Inc.

INDUSTRY

lead

University of Kansas

OTHER

NCT00222170 - Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD) | Biotech Hunter | Biotech Hunter